Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Clinical Endocrinology
|
September 1, 1999
Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study
E R Christ, M H Cummings, P J Lumb, et al.
Clinical Endocrinology
|
September 1, 1994
The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients
D L Russell-Jones, G F Watts, A Weissberger, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 7, 2003
High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes
M L Healy, J Gibney, D L Russell-Jones, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 3, 2005
Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletes
M L Healy, J Gibney, C Pentecost, et al.
Diabetologia
|
August 27, 2009
Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes
F Smeeton, F Shojaee Moradie, R H Jones, et al.
Clinical Endocrinology
|
April 21, 1999
Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment
P V Carroll, M Umpleby, E L Alexander, et al.
Diabetes
|
September 1, 1997
rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM
P V Carroll, M Umpleby, G S Ward, et al.
Clinical Endocrinology
|
July 1, 1997
Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy
P V Carroll, A M Umpleby, E Albany, et al.
Clinical Endocrinology
|
March 14, 1998
The effect of an intravenous infusion of IGF-I and insulin on IGFBP-1, IGFBP-3, acid labile subunit, free and bound IGF-I, catecholamines and potassium in normal volunteers during an amino acid and glucose clamp
D L Russell-Jones, A M Umpleby, F Shojaee-Moradie, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1997
The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency
E R Christ, M H Cummings, N B Westwood, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Clinical Endocrinology
|
September 1, 1999
Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study
E R Christ, M H Cummings, P J Lumb, et al.
Clinical Endocrinology
|
September 1, 1994
The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients
D L Russell-Jones, G F Watts, A Weissberger, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 7, 2003
High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes
M L Healy, J Gibney, D L Russell-Jones, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 3, 2005
Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletes
M L Healy, J Gibney, C Pentecost, et al.
Diabetologia
|
August 27, 2009
Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes
F Smeeton, F Shojaee Moradie, R H Jones, et al.
Clinical Endocrinology
|
April 21, 1999
Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment
P V Carroll, M Umpleby, E L Alexander, et al.
Diabetes
|
September 1, 1997
rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM
P V Carroll, M Umpleby, G S Ward, et al.
Clinical Endocrinology
|
July 1, 1997
Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy
P V Carroll, A M Umpleby, E Albany, et al.
Clinical Endocrinology
|
March 14, 1998
The effect of an intravenous infusion of IGF-I and insulin on IGFBP-1, IGFBP-3, acid labile subunit, free and bound IGF-I, catecholamines and potassium in normal volunteers during an amino acid and glucose clamp
D L Russell-Jones, A M Umpleby, F Shojaee-Moradie, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1997
The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency
E R Christ, M H Cummings, N B Westwood, et al.
Page
of 6